Connect with us
Information

Australia
North America
World

Investing News NetworkYour trusted source for investing success

North America
Australia
World
My INN

Top Stocks

Top Resource Stocks

Top Weekly TSX Stocks
Top Weekly TSXV Stocks
Top Gold Stocks
Top Junior Gold Stocks
Top Copper Stocks
Top Lithium Stocks
Top Rare Earth Stocks
Top Graphite Stocks
Top Cobalt Stocks
Top Oil and Gas Stocks
Biggest Silver Stocks
Biggest Hydrogen Stocks

Top Tech Stocks

Top Generative AI Stocks
Top EV Stocks
Biggest AI Companies
Biggest Blockchain Stocks
Biggest Cryptocurrency-mining Stocks
Biggest Cybersecurity Companies
Biggest Robotics Companies
Biggest Social Media Companies
Biggest Technology ETFs
Artificial Intellgience ETFs
Robotics ETFs
Canadian Cryptocurrency ETFs

Top Life Science Stocks

Cannabis Weekly Round-Up
Top Alzheimer's Treatment Stocks
Top Biotech Stocks
Top Plant-based Food Stocks
Biggest Cannabis Stocks
Biggest Pharma Stocks
Biggest Stem Cell Stocks
Longevity Stocks to Watch
Psychedelics Stocks to Watch
Small Biotech ETFs to Watch
Top Life Science ETFs
Biggest Pharmaceutical ETFs

Private Placements

Reports & Guides

Trending

Trending Articles

How Would a New BRICS Currency Affect the US Dollar? (Updated 2024)

Could the Silver Price Really Hit $100 per Ounce? (Updated 2024)

Reducing Reliance on China for Rare Earths Production and Processing

Can You Invest in Elon Musk’s Neuralink? (Updated 2024)

Rick Rule: Gold, Silver, Uranium — Key Price Drivers and What to Watch Now

A State-by-State Guide to Cannabis in Australia (Updated 2024)

Rare Earths Stocks: 9 Biggest Companies in 2024

Uranium Stocks: 5 Biggest Companies in 2024

Top 10 Oil-producing Countries (Updated 2024)

Trending Press Releases

Corporate Update

Westgold Strategic Alliance and Placement

Aston Bay and American West Metals Announce C$17.1 Million Royalty Package for the Storm Copper Project, Canada

Radiopharm Receives Strategic Investment for up to A$18 million

Radiopharm Theranostics Limited (ASX: RAD) – Trading Halt

Charbone Hydrogen is More Than Doubling its Phase 1 Electrolyzer Capacity to Power Up Green Hydrogen Production at the Sorel-Tracy, Quebec Plant

More Press Releases

Trending Companies

Galan Lithium

GLN:AU

Cardiol Therapeutics

CRDL:CA

Melodiol Global Health

ME1:AU

EMU NL

EMU:AU

Trending Reports

2024 Gold Outlook Report

2024 Lithium Market Outlook (Updated for Q2)

2024 Copper Outlook Report

Silver Price Forecast - What Happened And Where Do We Go From Here?

More Outlook Reports

Resource

Precious Metals
Gold
Silver
Platinum
Palladium

Battery Metals
Lithium
Cobalt
Graphite
Vanadium
Manganese

Base Metals
Copper
Nickel
Iron
Zinc

Energy
Uranium
Oil and Gas

Critical Metals
Rare Earths

Gems
Diamonds

Industrial Metals

Agriculture

Popular Lists

Top Weekly TSX Stocks
Top Weekly TSXV Stocks
Top Gold Stocks
Top Junior Gold Stocks
Top Copper Stocks
Top Lithium Stocks
Top Rare Earth Stocks
Top Graphite Stocks
Top Cobalt Stocks
Top Oil and Gas Stocks
Biggest Silver Stocks
Biggest Hydrogen Stocks

Investing Ideas

Resource Companies
Private Placements
Press Releases
CEO Interviews
INNspired
Uranium Stocks Index

Outlook Reports

Lithium Outlook
Oil and Gas Outlook
Gold Outlook Report
Uranium Outlook
Rare Earths Outlook
All Outlook Reports

Investing Guides

Start Here: Investing in Gold
Start Here: Investing in Silver
Start Here: Investing in Uranium
Start Here: Investing in Lithium
Start Here: Investing in Oil & Gas
All Investing Guides

Tech

Artificial Intelligence
Blockchain & Crypto
Cleantech
Cybersecurity
Emerging Tech
Fintech
Gaming & Esports
Nanoscience

Popular Lists

Top Generative AI Stocks
Top EV Stocks
Biggest AI Companies
Biggest Blockchain Stocks
Biggest Cryptocurrency-mining Stocks
Biggest Cybersecurity Companies
Biggest Robotics Companies
Biggest Social Media Companies
Biggest Technology ETFs
Artificial Intellgience ETFs
Robotics ETFs
Canadian Cryptocurrency ETFs

Investing Ideas

Tech Companies
Private Placements
Press Releases
CEO Interviews
INNspired

Outlook Reports

Artificial Intelligence Outlook
EV Outlook
Cleantech Outlook
Crypto Outlook
Tech Outlook
All Market Outlook Reports

Investing Guides

Start Here: Investing in AI
Start Here: Investing in Cleantech
Start Here: Robotics
Start Here: Investing in Emerging Tech
Start Here: Investing in Esports
All Investing Guides

Life Science

Biotech
Cannabis
Pharmaceutical
Psychedelics
Medical Devices

Popular Lists

Cannabis Weekly Round-Up
Top Alzheimer's Treatment Stocks
Top Biotech Stocks
Top Plant-based Food Stocks
Biggest Cannabis Stocks
Biggest Pharma Stocks
Longevity Stocks to Watch
Psychedelics Stocks to Watch
Top Cobalt Stocks
Small Biotech ETFs to Watch
Top Life Science ETFs
Biggest Pharmaceutical ETFs

Investing Ideas

Life Science Companies
Private Placements
Press Releases
CEO Interviews
INNspired

Outlook Reports

Life Science Outlook
Biotech Outlook
Cannabis Outlook
Pharma Outlook
Psychedelics Outlook
All Market Outlook Reports

Investing Guides

Start Here: Investing in Biotech
Start Here: Investing in Pharma
Start Here: Investing in Psychedelics
Start Here: Investing in Cannabis
Start Here: Investing in Genetics
All Investing Guides

Artificial Intelligence

Gold Price
Silver Price
Copper Price
Oil Price
Uranium
Artificial Intelligence

nasdaq regn us

POPULAR ARTICLES

Dupixent® Recommended for EU Approval by the CHMP to Treat Patients with COPD

Dupixent® Recommended for EU Approval by the CHMP to Treat Patients with COPD

Update on FDA Priority Review of Dupixent® for the Treatment of COPD Patients with Type 2 Inflammation

Update on FDA Priority Review of Dupixent® for the Treatment of COPD Patients with Type 2 Inflammation

Biohaven Doses First Patient with its Novel Trop-2 Directed Antibody Drug Conjugate BHV-1510 in Advanced or Metastatic Epithelial Tumors

Biohaven Doses First Patient with its Novel Trop-2 Directed Antibody Drug Conjugate BHV-1510 in Advanced or Metastatic Epithelial Tumors

LATEST ARTICLES

Promising Anti-tumor Activity of Novel Costimulatory Bispecific Antibody REGN7075 in Combination with Libtayo® to be Reported at ASCO

Promising Anti-tumor Activity of Novel Costimulatory Bispecific Antibody REGN7075 in Combination with Libtayo® to be Reported at ASCO

Dupixent® Late-Breaking Data from NOTUS Confirmatory Phase 3 COPD Trial Presented at ATS and Published in The New England Journal of Medicine

Dupixent® Late-Breaking Data from NOTUS Confirmatory Phase 3 COPD Trial Presented at ATS and Published in The New England Journal of Medicine

More than $9 Million Awarded to High School Scientists and Engineers at the Regeneron International Science and Engineering Fair 2024

More than $9 Million Awarded to High School Scientists and Engineers at the Regeneron International Science and Engineering Fair 2024

Kirby McInerney LLP is Investigating Potential Shareholder Claims Against Regeneron Pharmaceuticals, Inc.

Kirby McInerney LLP is Investigating Potential Shareholder Claims Against Regeneron Pharmaceuticals, Inc.

Dupixent® sBLA Accepted for FDA Priority Review for Treatment of Adolescents with Chronic Rhinosinusitis with Nasal Polyposis

Dupixent® sBLA Accepted for FDA Priority Review for Treatment of Adolescents with Chronic Rhinosinusitis with Nasal Polyposis

Dupixent® sBLA Accepted for FDA Priority Review for Treatment of Adolescents with Chronic Rhinosinusitis with Nasal Polyposis

Dupixent® sBLA Accepted for FDA Priority Review for Treatment of Adolescents with Chronic Rhinosinusitis with Nasal Polyposis

Dupixent® sBLA Accepted for FDA Priority Review for Treatment of Adolescents with Chronic Rhinosinusitis with Nasal Polyposis

Dupixent® sBLA Accepted for FDA Priority Review for Treatment of Adolescents with Chronic Rhinosinusitis with Nasal Polyposis

Dupixent® sBLA Accepted for FDA Priority Review for Treatment of Adolescents with Chronic Rhinosinusitis with Nasal Polyposis

Dupixent® sBLA Accepted for FDA Priority Review for Treatment of Adolescents with Chronic Rhinosinusitis with Nasal Polyposis

Latest DB-OTO Results Show Dramatically Improved Hearing to Normal Levels in a Child with Profound Genetic Deafness within 24 Weeks and Initial Hearing Improvements in a Second Child at 6 Weeks

Latest DB-OTO Results Show Dramatically Improved Hearing to Normal Levels in a Child with Profound Genetic Deafness within 24 Weeks and Initial Hearing Improvements in a Second Child at 6 Weeks

Regeneron Announces Investor Conference Presentations

Regeneron Announces Investor Conference Presentations

Regeneron Announces Investor Conference Presentations

Regeneron Announces Investor Conference Presentations

Regeneron Announces Investor Conference Presentations

Regeneron Announces Investor Conference Presentations

Latest News

Canadian Investment Regulatory Organization Trade Resumption - Q

Vizsla Copper Begins Drilling at Woodjam Copper-Gold Property

Zodiac Gold Completes Pre-Drilling Satellite Data Interpretation at the Alasala Target on the Todi Gold Project

E-Power Resources Inc. Announces Commencement of the 2024 Tetepisca Exploration Program

South Star Battery Metals Announces Successful Metallurgical Results for its BamaStar Graphite Project in Alabama, USA